SM

Sabby Management Portfolio holdings

AUM $12M
1-Year Est. Return 79.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-79.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$77M
AUM Growth
+$48.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$31.2M
2
+$6.99M
3
+$3.94M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$3.78M
5
MTVA
MetaVia Inc
MTVA
+$3.18M

Top Sells

1
+$2.89M
2
+$2.31M
3
+$2.11M
4
OTLK icon
Outlook Therapeutics
OTLK
+$1.94M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$1.78M

Sector Composition

1 Healthcare 73.45%
2 Industrials 1.66%
3 Consumer Discretionary 0.57%
4 Technology 0.52%
5 Financials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$27.8M 36.09%
+103,902
2
$10.5M 13.68%
105,280
+70,870
3
$4.62M 5.99%
+71,893
4
$2.89M 3.75%
+1,086,031
5
$2.88M 3.73%
+498,259
6
$2.74M 3.56%
+113,353
7
$2.42M 3.14%
+1,531,446
8
$1.87M 2.43%
+88
9
$1.72M 2.23%
40,500
-8,488
10
$1.66M 2.15%
+31,320
11
$1.36M 1.77%
+1,342
12
$1.32M 1.71%
2,947
+1,112
13
$1.27M 1.66%
+47,767
14
$1.25M 1.62%
+9,130
15
$1.15M 1.49%
+34,500
16
$950K 1.23%
+73,094
17
$926K 1.2%
+125,752
18
$867K 1.13%
842,210
-193,186
19
$800K 1.04%
+102,891
20
$776K 1.01%
+13,041
21
$747K 0.97%
+313
22
$676K 0.88%
7,278
+5,383
23
$642K 0.83%
+53,009
24
$450K 0.58%
87,319
-24,836
25
$441K 0.57%
+650,000
1
2 3 4 5